Table 1 Consensus Rules
From: coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
High Consensus | ≥70% of all voters rated the outcome 7, 8, or 9 |
Patient-Important | < 70% of all voters rated the outcome 7, 8 or 9, BUT ≥70% of the patient group rated the outcome 7, 8, or 9 |
Eliminate | < 70% of all voters rated the outcome 7, 8 or 9, AND < 70% of the patient group rated the outcome 7, 8, or 9 |